NAPSA has congratulated the SHPA on the support for its inaugural Residency Program, which is set to commence in 2017.
“Thirty-two accreditation applications representing 54 hospitals is an outstanding result for this first accreditation round,” says NAPSA president Shefali Parekh.
“Importantly, it’s providing potential opportunities for over 130 early career pharmacists to fast-track their professional development by participating in an intensive experiential learning residency program.
“NAPSA is committed to advocating for Australian pharmacy students to ensure their future is prosperous. We recognise that a future pharmacy workforce must evolve to ensure it has the capacity, capability and flexibility to function within an ever-changing healthcare system,” Parekh says.
“But to achieve this capability, future pharmacists need not just solid undergraduate training, but challenging and innovative workplace learning like that to be delivered by the SHPA Residency Program.”
Immediate past vice president of NAPSA and NAPSA nominee to the SHPA Residency Project Steering Committee, Matthew Scott, says that the program has represented an exciting opportunity to be part of the Committee and contribute students’ perspective.
“Entering my intern year next year, I know this is the sort of experiential learning I want and expect if I am to maximise my contribution to patient care as a pharmacist,” Scott says.
“Having NAPSA representation on the steering committee is just another example of the great partnership between NAPSA and SHPA,” says Parekh.
“NAPSA is proud to be in a working partnership with the SHPA, as it means both organisations continue to share ideas and innovation on what initiatives will be of mutual benefit to our members,” she says.